A multicenter, randomized, double blind, comparative study to evaluate the safety, tolerability, and efficacy of 2 dosing regimens of caspofungin in the treatment of invasive candidiasis in adults
Phase 1
- Conditions
- Treatment of invasive candidiasis in adultsMedDRA version: 6.1 Level: PT Classification code 10007152
- Registration Number
- EUCTR2005-004504-36-IT
- Lead Sponsor
- MERCK SHARP DOHME
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method